The Use of Self-reported Symptoms as a Proxy for Acute Organophosphate Poisoning Among Nepali Farmers
NCT ID: NCT02838303
Last Updated: 2023-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2014-09-30
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Farming, Personal Protective Equipment, Nepal
NCT02137317
Organophosphate Pesticides and Human Reproductive Health
NCT00046124
Pesticide Exposure Pathways for Farmworker Children
NCT00013754
Incidence and Mortality of Childhood Cancer Among Children of Farmer Pesticide Applications
NCT00339378
Effects of Pesticide Exposure on Neurodevelopment/Growth/Respiratory Health
NCT00021658
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Initial spray session: organophosphate. Crossover spray session: placebo
Organophosphate
Chlorpyrifos 50% plus cypermethrin 5%, WHO Class II: Moderately hazardous
Placebo
Multineem, WHO Class U: Unlikely to present acute hazard in normal use
Group B
Initial spray session: placebo. Crossover spray session: organophosphate
Organophosphate
Chlorpyrifos 50% plus cypermethrin 5%, WHO Class II: Moderately hazardous
Placebo
Multineem, WHO Class U: Unlikely to present acute hazard in normal use
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Organophosphate
Chlorpyrifos 50% plus cypermethrin 5%, WHO Class II: Moderately hazardous
Placebo
Multineem, WHO Class U: Unlikely to present acute hazard in normal use
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* minimum age 18 years
* hand pressured backpack sprayer usage
* used to spray with moderately to extremely hazardous pesticides according to the World Health Organization's (WHO) Pesticide Hazard Classification
Exclusion Criteria
* unwilling to stay pesticide-free seven days prior to each of the two spray sessions
* medical conditions interfering with PchE activity (liver disease, acute infection, chronic malnutrition, heart attack, cancer, obstructive jaundice, inflammation caused by various diseases, or use of pyridostigmine drugs)
18 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Augustinus Fonden
OTHER
Bispebjerg Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dea Haagensen Kofod
MB
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dea H. Kofod, MB
Role: PRINCIPAL_INVESTIGATOR
Department of Occupational and Environmental Medicine, Bispebjerg Frederiksberg Hospital, University of Copenhagen
References
Explore related publications, articles, or registry entries linked to this study.
Kofod DH, Jors E, Varma A, Bhatta S, Thomsen JF. The use of self-reported symptoms as a proxy for acute organophosphate poisoning after exposure to chlorpyrifos 50% plus cypermethrin 5% among Nepali farmers: a randomized, double-blind, placebo-controlled, crossover study. Environ Health. 2016 Dec 13;15(1):122. doi: 10.1186/s12940-016-0205-1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12205-01-57-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.